Fujiwara and colleagues: artificial surfactant for neonatal respiratory distress

What changed

A plausible bedside surfactant-replacement capability was demonstrated in a small severe neonatal series.

Scientific scope

1980 six-author uncontrolled series; not a randomized efficacy/safety conclusion for all preterm infants.

Evidence

The linked sources identify this contribution and its scope. WRS has not independently reconstructed the scientific claims. This is a small 1980 intervention series, not a randomized trial or an unconditional claim of safety and efficacy across all preterm infants.

Contributors

• T. Fujiwara · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.
• H. Maeta · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.
• S. Chida · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.
• T. Morita · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.
• Y. Watabe · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.
• T. Abe · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.

• Fujiwara et al., Artificial Surfactant Therapy in Hyaline-Membrane Disease

Provisional WRS assessment, edition 2026-10-16.1. Independent expert calibration is pending. This grade does not certify correctness or assign ownership.

Full scientific record · Browse contribution grades · Request a correction